In this context, cofilin-1 – a small protein of 18 kDa – has been widely studied as a biomarker of a more aggressive phenotype of different types of cancer such as breast, gastrointestinal and NSCLC [12-14]. This evidence concerns the gene CFL1 and non-small cell lung carcinoma.